Xiangxue Pharmaceutical (300147) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Based on the latest financial reports, Xiangxue Pharmaceutical (300147) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.64 Million ≈ $11.07 Million USD) by net assets (CN¥1.10 Billion ≈ $160.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Xiangxue Pharmaceutical to measure how much of total assets are equity-financed.

Xiangxue Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Xiangxue Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300147 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Xiangxue Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xiangxue Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TVS Supply Chain Solutions Limited NSE:TVSSCS	0.221x
Jiangsu Province Commun SHG:603018	0.011x
Jasmine Telecom Systems Public Company Limited BK:JTS	0.120x
Shenzhen Textile Holdings Co Ltd SHE:000045	-0.037x
Cars.com Inc NYSE:CARS	0.086x
Fuan Pharmaceutical Group Co SHE:300194	0.023x
Abaxx Technologies Inc NEO:ABXX	-0.155x
TMK KLSE:5330	N/A

Annual Cash Flow Conversion Efficiency for Xiangxue Pharmaceutical (2007–2025)

The table below shows the annual cash flow conversion efficiency of Xiangxue Pharmaceutical from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300147 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥43.95 Million ≈ $6.43 Million	CN¥139.63 Million ≈ $20.43 Million	3.177x	+25054.40%
2024-12-31	CN¥1.44 Billion ≈ $210.55 Million	CN¥18.17 Million ≈ $2.66 Million	0.013x	-88.91%
2023-12-31	CN¥2.31 Billion ≈ $338.50 Million	CN¥263.44 Million ≈ $38.55 Million	0.114x	+41.15%
2022-12-31	CN¥2.82 Billion ≈ $412.39 Million	CN¥227.38 Million ≈ $33.27 Million	0.081x	+17.71%
2021-12-31	CN¥3.76 Billion ≈ $549.88 Million	CN¥257.56 Million ≈ $37.69 Million	0.069x	+13.35%
2020-12-31	CN¥4.25 Billion ≈ $622.35 Million	CN¥257.18 Million ≈ $37.63 Million	0.060x	+199.49%
2019-12-31	CN¥4.11 Billion ≈ $601.66 Million	CN¥83.02 Million ≈ $12.15 Million	0.020x	-11.21%
2018-12-31	CN¥4.01 Billion ≈ $587.12 Million	CN¥91.24 Million ≈ $13.35 Million	0.023x	-19.37%
2017-12-31	CN¥3.88 Billion ≈ $568.31 Million	CN¥109.53 Million ≈ $16.03 Million	0.028x	-47.65%
2016-12-31	CN¥3.68 Billion ≈ $539.14 Million	CN¥198.48 Million ≈ $29.04 Million	0.054x	+19.47%
2015-12-31	CN¥3.55 Billion ≈ $518.89 Million	CN¥159.89 Million ≈ $23.40 Million	0.045x	-49.04%
2014-12-31	CN¥1.87 Billion ≈ $273.82 Million	CN¥165.58 Million ≈ $24.23 Million	0.088x	-53.92%
2013-12-31	CN¥1.71 Billion ≈ $250.23 Million	CN¥328.37 Million ≈ $48.05 Million	0.192x	+148.14%
2012-12-31	CN¥1.54 Billion ≈ $224.85 Million	CN¥118.91 Million ≈ $17.40 Million	0.077x	+271.56%
2011-12-31	CN¥1.42 Billion ≈ $207.64 Million	CN¥29.55 Million ≈ $4.32 Million	0.021x	-37.21%
2010-12-31	CN¥1.37 Billion ≈ $200.56 Million	CN¥45.47 Million ≈ $6.65 Million	0.033x	-75.75%
2009-12-31	CN¥337.62 Million ≈ $49.41 Million	CN¥46.19 Million ≈ $6.76 Million	0.137x	-51.75%
2008-12-31	CN¥196.54 Million ≈ $28.76 Million	CN¥55.72 Million ≈ $8.15 Million	0.284x	-60.67%
2007-12-31	CN¥191.45 Million ≈ $28.02 Million	CN¥138.02 Million ≈ $20.20 Million	0.721x	--

About Xiangxue Pharmaceutical

SHE:300147 China Biotechnology

Market Cap

$653.17 Million

CN¥4.46 Billion CNY

Market Cap Rank

#10765 Global

#2897 in China

Share Price

CN¥6.75

Change (1 day)

-3.30%

52-Week Range

CN¥6.26 - CN¥11.74

All Time High

CN¥25.81